Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_assertion type Assertion NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_head.
- NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_assertion description "[To better understand pathogenesis of ATL, we developed a novel xenogeneic engraftment model in which primary ATL cells are intravenously transplanted into neonatal nonobese diabetic (NOD)/severe-combined immunodeficiency (SCID)/beta2-microglobulin(null) (NOD/SCID/beta2m(null)) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_provenance.
- NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_assertion evidence source_evidence_literature NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_provenance.
- NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_assertion SIO_000772 15959532 NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_provenance.
- NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_assertion wasDerivedFrom befree-20150227 NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_provenance.
- NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_assertion wasGeneratedBy ECO_0000203 NP494129.RAWrnBJ4f4Y66-g-ESiccrYM48C4wpKF2Ov2Tvv94QMnw130_provenance.